indole has been researched along with Experimental Mammary Neoplasms in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Most estrogen receptor positive (ER +) breast cancers depend on ER signaling pathway to develop." | 1.56 | Design, syntheses and evaluations of novel indole derivatives as orally selective estrogen receptor degraders (SERD). ( Chan, CC; Chen, S; Ding, CZ; Dong, J; Gu, Q; He, H; Hu, G; Hu, L; Li, J; Li, X; Lu, J; Shen, L; Sun, D; Wang, TL; Xia, Y; Zeng, X; Zhu, Y, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wittmann, C | 1 |
| Sivchenko, AS | 1 |
| Bacher, F | 1 |
| Tong, KKH | 1 |
| Guru, N | 1 |
| Wilson, T | 1 |
| Gonzales, J | 1 |
| Rauch, H | 1 |
| Kossatz, S | 1 |
| Reiner, T | 1 |
| Babak, MV | 1 |
| Arion, VB | 1 |
| Dong, J | 1 |
| Wang, TL | 1 |
| Lu, J | 1 |
| Ding, CZ | 1 |
| Hu, L | 1 |
| Hu, G | 1 |
| He, H | 1 |
| Zeng, X | 1 |
| Li, X | 1 |
| Sun, D | 1 |
| Zhu, Y | 1 |
| Shen, L | 1 |
| Gu, Q | 1 |
| Chan, CC | 1 |
| Xia, Y | 1 |
| Li, J | 1 |
| Chen, S | 1 |
2 other studies available for indole and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Inhibition of Microtubule Dynamics in Cancer Cells by Indole-Modified Latonduine Derivatives and Their Metal Complexes.
Topics: Animals; Antineoplastic Agents; Cell Survival; Coordination Complexes; Crystallography, X-Ray; Drug | 2022 |
Design, syntheses and evaluations of novel indole derivatives as orally selective estrogen receptor degraders (SERD).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Dose-Res | 2020 |